Cyted Health

Our EndoSign® cell collection device has received 510(k) clearance from the FDA, enabling earlier and more efficient detection of esophageal pre-cancer and other conditions. #DetectToProtect #FDA

Expanding NHS FIT screening is a major step for early bowel cancer detection. But rising referrals mean #endoscopy capacity must be protected. Triage tools such as EndoSign® for oesophageal risk could help free capacity for bowel cancer patients. endosign.com/hcp/overview

For Oesophageal Cancer Awareness Month, we are sharing Eddie’s story - a powerful reminder of why early detection matters. After decades of heartburn, and no new symptoms, the EndoSign® test helped catch his cancer early. Watch here: youtu.be/4ICuevA92rQ

Great to see the National Cancer Plan backing proven diagnostics like the EndoSign® capsule sponge test. It’s already used across the NHS—now national policy can help end postcode variation and ensure more patients benefit from #earlierdiagnosis. gov.uk/government/new…

We've done it again! Cyted Health has been shortlisted for the @HSJnews Independent Healthcare Providers Awards 2026, this time in the Best Provider of Community and Primary Care category for the #CYTOPRIME2 project. Thank you to all involved! lnkd.in/eEPUhNik

🚨 🗣️ Fantastic new original research from the CYTOPRIME 2 study 💥. Thanks to @DrDanielleMorr1 @CytedHealth and team for demonstrating that capsule sponge testing 🧽 is a practical and scalable approach to earlier detection of Barrett's oesophagus and oesophageal cancer 👏 . Should we be implementing this in the community as a screening test for patients with GORD 🤔 💭 ?! fg.bmj.com/content/early/… @PhilSmithIsBack @OTavabie @dr_aditi_kumar @TrevorTabone @eathar_s @IrenePerezMD @KGananandan @zare_benjamin @medicalreg @dtleiberman @BASLedu @BSGtrainees @WorldGastroOrg @ulstergastro @pancreatitis_nl @SEEDendoscopia @EASLedu @AmCollegeGastro @Aegastro @SAGES_updates @UHSEndoscopy @WAGE_media #GITwitter #gastroenterology #Endoscopy #MedEd

We’re proud to have been shortlisted alongside @NHSScotlandRBLX for the @HSJnews Independent Healthcare Provider of the Year Award 2025! This second nomination is a real testament to our work enhancing early cancer detection across the UK.

Delighted to be featured on @TheLancet podcast sharing our findings from our recent BE surveillance paper published in the Lancet! Tune in wherever you get your podcasts: thelancet.com/multimedia/pod… #podcast #surveillance #barretts

New in The Lancet: a major step forward in Barrett’s esophagus surveillance. Our real-world study shows how a capsule sponge test + biomarker analysis can stratify risk - helping to prioritise care & streamline endoscopy pressures. thelancet.com/journals/lance…

We’re at #BSGLive2025 in Glasgow! Visit the Cyted stand to see how EndoSign® is transforming early detection in esophageal health - improving patient outcomes and streamlining GI pathways across the NHS. Come along to meet our team!

Today is World Barrett’s Oesophagus Day!💚 Barrett’s oesophagus is a condition where the normal cells in the oesophagus (also called the gullet) are replaced with abnormal cells. Find out more about Barrett’s oesophagus via the link here: loom.ly/a_Zb1DQ (🧵1/5)

📅 Today is World Barrett's Oesophagus Day Persistent heartburn 🔥 for over 3 weeks could be #MoreThanJustHeartburn. Don’t ignore it — speak to your GP. 🩺 More info 👉 heartburncanceruk.org/barretts-oesop…

Today is #WorldBarrettsDay. Barrett's Esophagus is a key risk factor for esophageal cancer. At Cyted, we’re advancing access to early, accurate diagnosis with our EndoSign® platform helping patients get treated sooner and live healthier lives.

That’s a wrap on #DDW2025! Grateful for the inspiring conversations, connections, and the chance to share our latest in early detection. Thank you to all who connected - here’s to advancing GI health together!

#DDW2025 today! Catch Dr. W. Keith Tan, 2:45 - 3:00 PM PDT, presenting groundbreaking results on using the capsule sponge to transform Barrett’s Esophagus surveillance. Minimally invasive. Smarter risk stratification. Better outcomes. Let’s connect!

Today at #DDW2025 - our abstract on 'Clinical Validation of a DNA Methylation Panel for Non-Endoscopic Diagnosis of Barrett’s Esophagus in a Multicenter Cohort' will be featured in a Poster Session! 📷 May 4, 2025 | 📷 12:30 – 1:30 PM PDT

Today at #DDW2025! @SarahKillcoyne will be presenting research using Cyted’s EndoSign® device to assess EoE disease activity & remission non-endoscopically. 📅 May 3, 2025 | ⏰ 4:00–5:30 PM PDT 📍 What’s New in Eosinophilic Esophagitis? Attending? Let's connect!

#DDW2025 kicks off today! We’re excited to share our latest research in early detection and connect with the GI community in San Diego. Attending? Let’s connect and shape the future of esophageal health together!

Our CEO Marcel Gehrung PhD, recently spoke with @thetimes about Cyted Health’s strategic expansion into the US. Despite market uncertainties, he highlights Cyted’s strong growth trajectory - enrolling patients in the DETECT-ME study across 18 US sites. lnkd.in/egdUCAqu

We’re heading to #DDW2025! Join us in San Diego from May 3–6 as we highlight groundbreaking research and connect with leaders in GI diagnostics. Let’s reimagine the future of esophageal health together.

April is global Esophageal Cancer Awareness Month - a reminder that persistent heartburn isn't just uncomfortable, it can be a warning sign. Esophageal cancer is often caught too late, but it doesn’t have to be. Awareness and early action can save lives.